In Vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms | Zendy

Guanhua Xue | Zendy; Donna M. Crabb | Zendy; Li Xiao | Zendy; Yu Liu | Zendy; Ken B. Waites | Zendy

Open Access

In Vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms

Author(s) -

Guanhua Xue,

Donna M. Crabb,

Li Xiao,

Yu Liu,

Ken B. Waites

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01348-18

Subject(s) - moxifloxacin , mycoplasma hominis , microbiology and biotechnology , ureaplasma , mycoplasma genitalium , levofloxacin , mycoplasma , mycoplasma pneumoniae , azithromycin , clindamycin , mycoplasmataceae , quinolone , biology , antimicrobial , virology , medicine , mollicutes , antibiotics , chlamydia trachomatis , pneumonia

Levonadifloxacin (WCK 771) was evaluated against 68 type strains and clinical isolates ofMycoplasma genitalium ,Mycoplasma hominis ,Mycoplasma pneumoniae , andUreaplasma spp. in comparison with moxifloxacin, levofloxacin, tetracycline, and azithromycin or clindamycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research